Scienture Holdings, Inc. has entered into a securities purchase agreement with certain institutional investors to purchase 3,225,000 shares of common stock at an offering price of $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before deducting placement agent fees and other offering expenses.
The offering is expected to close on August 15, 2025, subject to customary closing conditions.
Offering Details
3,225,000 shares of common stock at $1.20 per share
Gross Proceeds
Approximately $3.9 million expected before deductions
Closing Date
Expected on August 15, 2025
- The securities purchase agreement with institutional investors signifies a strategic move to raise capital for Scienture Holdings, Inc.
- The successful offering is expected to enhance the financial position of the company and support its growth initiatives.
The entry into the securities purchase agreement demonstrates Scienture Holdings, Inc.'s commitment to securing funding for its pharmaceutical operations and advancing its mission to provide enhanced value to patients and healthcare systems.